Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Precision Biosciences (DTIL) Leases (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Leases for 6 consecutive years, with $5.8 million as the latest value for Q4 2025.

  • Quarterly Leases fell 18.12% to $5.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Dec 2025, down 18.12% year-over-year, with the annual reading at $5.8 million for FY2025, 18.12% down from the prior year.
  • Leases for Q4 2025 was $5.8 million at Precision Biosciences, down from $6.1 million in the prior quarter.
  • The five-year high for Leases was $8.3 million in Q4 2023, with the low at $1.1 million in Q3 2023.
  • Average Leases over 5 years is $5.3 million, with a median of $5.8 million recorded in 2021.
  • The sharpest move saw Leases crashed 67.28% in 2023, then skyrocketed 587.08% in 2024.
  • Over 5 years, Leases stood at $4.2 million in 2021, then plummeted by 53.01% to $2.0 million in 2022, then skyrocketed by 320.72% to $8.3 million in 2023, then decreased by 14.2% to $7.1 million in 2024, then dropped by 18.12% to $5.8 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $5.8 million, $6.1 million, and $6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.